Real-time enrollment status for this extrapulmonary neuroendocrine cancer (epnec) clinical trial
Current Status
Recruiting
Checked: July 23, 2026 at 2:32 AM UTC
| NCT Number | NCT07544654 |
| Recruiting Status | Recruiting |
| Condition | Extrapulmonary Neuroendocrine Cancer (epNEC) |
| Phase | PHASE3 |
| Target Enrollment | 390 participants |
| Active Locations | 21 sites in the US |
| Sponsor | Boehringer Ingelheim |
| Last Updated on CT.gov | July 22, 2026 (Yesterday) |
As of July 23, 2026: Clinical trial NCT07544654 is currently recruiting participants. This phase3 study for extrapulmonary neuroendocrine cancer (epnec) is actively seeking new participants at 21 locations across the United States. The study is sponsored by Boehringer Ingelheim. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07544654 is actively recruiting participants as of July 23, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 21 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07544654 was last updated Yesterday (July 22, 2026). HelloStudys verifies this status automatically.